OS Therapies Incorporated (OSTX)
NYSEAMERICAN: OSTX · Real-Time Price · USD
2.390
+0.130 (5.75%)
Aug 29, 2025, 4:00 PM - Market closed

OS Therapies Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-14.28-8.88-7.79-6.25-7.42-6.03
Depreciation & Amortization
0.1100000
Other Amortization
0.341.432.651.152.070.27
Stock-Based Compensation
2.50.29----
Other Operating Activities
-0.850.010.120.360.372.38
Change in Accounts Payable
0.03-1.051.350.220.860
Change in Other Net Operating Assets
0.580.920.670.73-0.280.96
Operating Cash Flow
-11.56-7.28-3.01-3.79-4.4-2.41
Capital Expenditures
-----0.01-0
Other Investing Activities
--00.230.210.16
Investing Cash Flow
-0.47-00.230.20.16
Short-Term Debt Issued
-0.25----
Long-Term Debt Issued
-1.53.163.822.953.6
Total Debt Issued
-1.753.163.822.953.6
Short-Term Debt Repaid
--0.25----
Long-Term Debt Repaid
------0.12
Total Debt Repaid
-0.25-0.25----0.12
Net Debt Issued (Repaid)
-0.251.53.163.822.953.48
Issuance of Common Stock
5.235.23---0
Other Financing Activities
2.66--0.28-0.170.1-
Financing Cash Flow
14.7412.782.873.653.053.48
Net Cash Flow
2.715.49-0.130.09-1.151.22
Free Cash Flow
-11.56-7.28-3.01-3.79-4.41-2.42
Free Cash Flow Per Share
-0.53-0.59-0.55-0.38-0.44-0.29
Cash Interest Paid
----0.010.01
Levered Free Cash Flow
-14.98-8.541.31-0.2-0.97-
Unlevered Free Cash Flow
-15.04-8.690.82-0.22-1.43-
Change in Working Capital
0.62-0.132.020.950.570.96
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q